menu
    • menu

    Company profile for Intellia Therapeutics

    NEW Drugs in Dev: 10
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Many of us pursuing work in the biotechnology industry are inspired by someone in our community who is living with a disease or the loss of a loved one. We know that rare and genetic diseases not only affect the people living with often debilitating and life-threatening symptoms, but that these disorders also significantly impact their families, friends and caregivers. Since the emergence of the breakthrough genome editing ...
    Many of us pursuing work in the biotechnology industry are inspired by someone in our community who is living with a disease or the loss of a loved one. We know that rare and genetic diseases not only affect the people living with often debilitating and life-threatening symptoms, but that these disorders also significantly impact their families, friends and caregivers. Since the emergence of the breakthrough genome editing technology CRISPR/Cas9, the science has moved fast in only a few years.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Intellia TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    40 Erie Street, Cambridge, MA 02139
    Telephone
    Telephone
    857-285-6200
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.intelliatx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    International Sweetener Colloquium

    Not Confirmed

    envelop Contact Supplier

    International Sweetener Colloquium

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Intellia Therapeutics To Discuss Q4 2025 Financials & Business
    Intellia Therapeutics To Discuss Q4 2025 Financials & Business

    19 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/19/3240983/0/en/Intellia-Therapeutics-to-Hold-Conference-Call-to-Discuss-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Business-Updates.html

    GLOBENEWSWIRE
    19 Feb 2026
    Share Share
    Intellia Therapeutics Discloses Inducement Grants Per Nasdaq Lr
    Intellia Therapeutics Discloses Inducement Grants Per Nasdaq Lr

    06 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/06/3233747/0/en/Intellia-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    06 Feb 2026
    Share Share
    Intellia Gets FDA Nod to Resume One Gene Therapy Trial
    Intellia Gets FDA Nod to Resume One Gene Therapy Trial

    27 Jan 2026

    // PRESS RELEASE

    https://ir.intelliatx.com/news-releases/news-release-details/intellia-therapeutics-announces-fda-lift-clinical-hold-magnitude

    PRESS RELEASE
    27 Jan 2026
    Share Share
    Intellia Therapeutics To Present At J.P. Morgan Healthcare
    Intellia Therapeutics To Present At J.P. Morgan Healthcare

    07 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/07/3214417/0/en/Intellia-Therapeutics-to-Present-at-the-44th-Annual-J-P-Morgan-Healthcare-Conference.html

    GLOBENEWSWIRE
    07 Jan 2026
    Share Share
    Intellia Reports Inducement Grants Under Nasdaq Rule 5635(c)(4)
    Intellia Reports Inducement Grants Under Nasdaq Rule 5635(c)(4)

    02 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/02/3212275/0/en/Intellia-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    02 Jan 2026
    Share Share
    Intellia Announces Inducement Grants Under Nasdaq Rule 5635(c)(4)
    Intellia Announces Inducement Grants Under Nasdaq Rule 5635(c)(4)

    05 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/05/3200972/0/en/Intellia-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    05 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search